Gland Pharma Limited (GLAND) — Net Asset Quality Index
Gland Pharma Limited (GLAND) has a Net Asset Quality Index of 82.8% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Rs125.11 Billion minus total liabilities of Rs21.53 Billion yields net assets of Rs103.58 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See GLAND days of operational coverage to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Gland Pharma Limited Net Asset Quality Index Over Time (2017–2026)
This chart shows how Gland Pharma Limited's Net Asset Quality Index has evolved across 10 annual periods from 2017 to 2026. As of March 2026, the index stands at 82.8%, representing net assets of Rs103.58 Billion against total assets of Rs125.11 Billion INR. Explore Gland Pharma Limited cash flow conversion to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Gland Pharma Limited (2017–2026)
The table below presents the year-by-year Net Asset Quality Index for Gland Pharma Limited from 2017 to 2026, covering 10 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Gland Pharma Limited (GLAND) market capitalisation.
| Year | Quality Index | Net Assets (INR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2026 | 82.8% | Rs103.58 Billion | Rs125.11 Billion | Rs21.53 Billion | ▲ +1.3 pp |
| 2025 | 81.5% | Rs91.51 Billion | Rs112.25 Billion | Rs20.74 Billion | ▼ -0.3 pp |
| 2024 | 81.8% | Rs87.24 Billion | Rs106.61 Billion | Rs19.37 Billion | ▼ -8.8 pp |
| 2023 | 90.7% | Rs79.59 Billion | Rs87.78 Billion | Rs8.19 Billion | ▼ -0.7 pp |
| 2022 | 91.4% | Rs71.58 Billion | Rs78.34 Billion | Rs6.76 Billion | ▲ +0.5 pp |
| 2021 | 90.9% | Rs59.03 Billion | Rs64.96 Billion | Rs5.93 Billion | ▲ +1.6 pp |
| 2020 | 89.2% | Rs36.46 Billion | Rs40.86 Billion | Rs4.40 Billion | ▲ +8.0 pp |
| 2019 | 81.2% | Rs28.62 Billion | Rs35.24 Billion | Rs6.62 Billion | ▼ -1.1 pp |
| 2018 | 82.3% | Rs24.10 Billion | Rs29.29 Billion | Rs5.19 Billion | ▼ -2.2 pp |
| 2017 | 84.5% | Rs20.90 Billion | Rs24.74 Billion | Rs3.84 Billion | — |